MSEGX
Price
$50.92
Change
+$1.65 (+3.35%)
Updated
May 8 closing price
Net Assets
3.77B
RGEBX
Price
$69.59
Change
+$0.51 (+0.74%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

MSEGX vs RGEBX

Header iconMSEGX vs RGEBX Comparison
Open Charts MSEGX vs RGEBXBanner chart's image
Morgan Stanley Inst Growth A
Price$50.92
Change+$1.65 (+3.35%)
VolumeN/A
Net Assets3.77B
American Funds Growth Fund of Amer R2E
Price$69.59
Change+$0.51 (+0.74%)
VolumeN/A
Net Assets283.8B
MSEGX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSEGX vs. RGEBX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSEGX is a Buy and RGEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 284B vs. MSEGX (3.77B). MSEGX pays higher dividends than RGEBX: MSEGX (0.43) vs RGEBX (0.00). MSEGX was incepted earlier than RGEBX: MSEGX (29 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than MSEGX (0.82). MSEGX is a more actively managed with annual turnover of: 39.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MSEGX: RGEBX (250) vs MSEGX (1000). MSEGX annual gain was more profitable for investors over the last year : 46.83 vs. RGEBX (2.88). RGEBX return over 5 years is better than : 40.75 vs. MSEGX (-11.27).
MSEGXRGEBXMSEGX / RGEBX
Total Expense Ratio0.821.0975%
Annual Report Gross Expense Ratio0.821.0975%
Fund Existence29 years11 years-
Gain YTD-1.735-2.59067%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.77B284B1%
Annual Yield % from dividends0.430.00-
Returns for 1 year46.832.881,624%
Returns for 3 years58.2932.03182%
Returns for 5 years-11.2740.75-28%
Returns for 10 years20.3854.7537%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDRX4.240.45
+11.87%
GoodRx Holdings
KAVL0.600.03
+4.37%
Kaival Brands Innovations Group
PNR93.531.75
+1.91%
Pentair plc
SUPV14.60N/A
N/A
Grupo Supervielle SA
BDSX0.35-0.08
-17.91%
Biodesix